3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
19
Ovarian Neoplasms
17
Neuroblastoma
15
Fallopian Tube Neoplasms
13
Neoplasms
6
Carcinoma, Ovarian Epithelial
6
Ganglioneuroblastoma
5
Brain Neoplasms
4
Uterine Cervical Neoplasms
3
Recurrence
3
Neoplasm Metastasis
3
Lung Neoplasms
3
Glioma
3
Central Nervous System Neoplasms
3
Sarcoma, Ewing
2
Rhabdoid Tumor
2
Retinoblastoma
2
Medulloblastoma
2
Leukemia, Myeloid, Acute
2
Wilms Tumor
1
Thrombocythemia, Essential
1
SCLC, Extensive Stage
1
SCLC
1
Rhabdomyosarcoma
1
Retinal Neoplasms
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pleuropulmonary blastoma
1
Peritoneal Neoplasms
1
Pediatric Brain Tumor
1
Interventions
regorafenib
2
ivosidenib
2
Proton Therapy
2
enasidenib
1
durvalumab
1
capivasertib
1
abemaciclib
1
Zoledronic Acid
1
Weight-Bearing
1
Taxes
1
Surveys and Questionnaires
1
Standard of Care
1
Range of Motion, Articular
1
Pharmacogenomic Testing
1
Paclitaxel
1
Immunoglobulin G
1
HhAntag691
1
Gemcitabine
1
Disulfides
1
Cisplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Chondrosarcoma
×
Topotecan
×
1 year
×
Clear all
No trials found.